FinTrust Capital Advisors’s Bausch Health BHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
$890 Hold
109
﹤0.01% 1283
2024
Q2
$760 Hold
109
﹤0.01% 1281
2024
Q1
$1.16K Hold
109
﹤0.01% 1153
2023
Q4
$875 Hold
109
﹤0.01% 1152
2023
Q3
$896 Buy
+109
New +$940 ﹤0.01% 1127
2022
Q2
Sell
-6,000
Closed -$137K 1214
2022
Q1
$137K Sell
6,000
-4,000
-40% -$97.8K 0.03% 354
2021
Q4
$276K Buy
+10,000
New +$268K 0.07% 244
2019
Q2
Sell
-35
Closed -$1K 1067
2019
Q1
$1K Buy
35
+10
+40% +$239 ﹤0.01% 1169
2018
Q4
$0 Buy
+25
New +$595 ﹤0.01% 1278

Other funds holding BHC

FinTrust Capital Advisors's BHC Position: Q3 2024 in Review

FinTrust Capital Advisors held its Bausch Health (BHC) position steady in Q3 2024 at 109 shares worth $890. The position accounts for ﹤0.01% of the portfolio, ranked #1283.

FinTrust Capital Advisors first reported a position in BHC in Q4 2018 and has held it in 9 quarters since. The position peaked at $276K in Q4 2021. 211 funds tracked by Wall St. Rank hold BHC as of Q3 2024.

  • FinTrust Capital Advisors held 109 shares of Bausch Health worth $890 as of Q3 2024.
  • FinTrust Capital Advisors left its Bausch Health share count unchanged in Q3 2024.
  • Bausch Health made up ﹤0.01% of FinTrust Capital Advisors's portfolio in Q3 2024, its #1283 holding.
  • FinTrust Capital Advisors first reported a position in Bausch Health in Q4 2018 and has held it in 9 quarters since.
  • FinTrust Capital Advisors's Bausch Health position peaked at $276K in Q4 2021.
  • 211 funds tracked by Wall St. Rank held Bausch Health as of Q3 2024.

Based on FinTrust Capital Advisors's 13F filing for Q3 2024, filed 11 Oct 2024.